| Flank |
To investigate the effects of aerobic exercise training starting at adolescence, on Walker 256 tumor growth and insulin secretion in adult rats |
8 x 107
|
MOREIRA et al., 201815
|
| To evaluate whether obese adult rats that were chronically treated with an antidiabetic drug, glibenclamide, exhibit resistance to rodent breast carcinoma growth |
8 x 107
|
FRANCO et al., 201716
|
| To identify mechanisms of inflammatory response in atrophy in cancer cachexia |
2 x 107
|
HENRIQUES et al., 201717
|
| To investigate the antitumor activity of the soluble fraction of polysaccharides, extracted fromcabernet franc red wine, in Walker-256 tumor-bearing rats |
2 x 107
|
STIPP et al., 201710
|
| To investigate the pioglitazone effects, isolated or associated with insulin, on insulin resistance, cachexia and metabolic disorders in cancer animal model |
8 x 107
|
SILVA et al., 201718
|
| To evaluate the in vivo antitumor effects and toxicity of a new Ru(II) compound, cis-(Ru[phen]2[ImH]2)2+ (also called RuphenImH [RuC]), against Walker-256 carcinosarcoma in rats |
1 x 107
|
SOUZA et al., 201714
|
| To analyse the modulatory effect of a leucine-rich diet on direct and indirect tumor-induced placental damage |
1 x 106
|
CRUZ et al., 201619
|
| To determine the effect of tumors on interstitial cells of Cajal in the rat jejunum and to investigate the effect of 2% L-glutamine on interstitial cells of Cajal and tumor-induced changes |
8 x 107
|
FRACARO et al, 201620
|
| To assess the effect of endostatin combined with a small dose of 32 P-colloidal in vivo
|
1 x 106
|
GAO et al., 20167
|
| To assess antioxidant effects of açaí seed extract on anorexia-cachexia induced by Walker-256 tumor |
1 x 107
|
NASCIMENTO et al., 201621
|
| To provide insight into adipocyte involvement in inflammation along the progression of cachexia |
2 x 107
|
NEVES et al., 201622
|
| To evaluate the metformin on Walker-256 tumor evolution and also on protein metabolism in gastrocnemius muscle and body composition |
1 x 106
|
OLIVEIRA et al. 201623
|
| To evaluate whether leucine supplementation ameliorates cachexia in the heart |
2,5 x 106
|
TONETO et al., 201624
|
| To evaluate whether a leucine-rich diet affects metabolomic derangements in serum and tumor tissues in tumor-bearing Walker-256 rats |
2,5 x 106
|
VIANA et al., 201625
|
| To evaluate the effect of dietary supplementation with 20 g/kg L-glutamine on the intrinsic innervation of the enteric nervous system in healthy and Walker 256 tumor-bearing Wistar rats during the development of experimental cachexia |
8 x 107
|
VICENTINI et al., 201626
|
| To investigate the pharmacokinetics profiles of ginsenoside Rg and ginsenoside Rh after oral administration of pure ginsenoside Rg were administered, and compare the difference of the pharmacokinetics profiles between normal and Walker 256 tumorbearing rats |
1 x 10 |
FAN et al., 201627
|
| To investigate the effect of fish oil supplementation on apoptosis protein expression in Walker 256 tumor bearing rats |
1 x 108
|
BORGHETTI et al, 201528
|
| To evaluate the in vivo antitumor actions and toxicity of the dichloromethane fraction of Moquiniastrum polymorphum subsp. floccosum (formerly Gochnatia polymorpha ssp. floccosa), composed of sesquiterpene lactones, against Walker-256 carcinosarcoma in rats |
1 x 107
|
MARTINS et al., 201513
|
| To investigate the effects of celecoxib and ibuprofen, both non-steroidal anti-inflammatory drugs, on the decreased gluconeogenesis observed in liver of Walker-256 tumor-bearing rats |
8 x 107
|
SOUZA et al., 201529
|
| To investigate the effect of a leucine-rich diet on protein metabolism in the foetal gastrocnemius muscles of tumor-bearing pregnant rats |
2,5 x 105
|
CRUZ et al., 201430
|
| To test the effect of metformin on the tumor growth in rats with metabolic syndrome |
8 x 107
|
FRANCO et al., 201431
|
| To investigate the effect of fish oil supplementation on tumor growth, cyclooxygenase 2, peroxisome proliferator-activated receptor gamma, and RelA gene and protein expression in Walker 256 tumor-bearing rats |
3 x 107
|
BORGHETTI et al., 20134
|
| To evaluate gluconeogenesis from alanine, pyruvate and glycerol, and related metabolic parameters in perfused liver from Walker-256 tumor-bearing rats on days 5, 8 and 12 of tumor development |
8 x 107
|
MOREIRA et al., 201332
|
| To investigate the effect of infliximab, an anti-tumor necrosis factor a monoclonal antibody, on the progression of cachexia and several metabolic parameters affected by the Walker-256 tumor in rats |
8 x 107
|
MIKSZA et al., 201312
|
| To describe effects of the resistance exercise training upon adipose tissue inflammation in cachexia |
3 x 107
|
DONATTO et al., 201333
|
| To describe set point of weight loss and how the different visceral adipose tissue depots contribute to this symptom |
2 x 107
|
BATISTA JR et al., 201234
|
| Tibia |
To investigate the effects of electroacupuncture on mechanical allodynia and cellular immunity of cancer-induced bone pain rats, and to further explore the potential mechanism |
3 x 105
|
LIANG et al., 201835
|
| To investigate the role of NF-κB in CIBP by regulating MCP-1/chemokine CC motif receptor-2 (CCR2) signaling pathway. |
1 x 106
|
WANG et al., 201836
|
| To investigate whether P2Y12R is involved in the establishment of cancer-induced bone pain model by inoculating Walker 256 breast cancer cells in the tibia and to examine the effect of P2Y12R antagonist on spinal neuroimmune activity in a cancer-induced bone pain model |
2 x 107
|
LIU et al., 201737
|
| To investigate the role of Suppressor of cytokine signaling 3 in dorsal root ganglion in the development of cancer-induced pain |
4 x 105
|
WEI et al., 201738
|
| To assess the antinociceptive effect of Tanshinone IIA on cancer-induced bone pain |
5 x 102
|
HAO et al., 201639
|
| To investigate whether spinal CCR5 and its downstream PKCγ pathway is involved in the maintenance of cancer-induced bone pain |
1 x 105
|
HANG et al., 201640
|
| To investigate the mechanisms underlying the anti-nociceptive effect of minocycline on bone cancer pain in rats |
4 x 105
|
SONG et al., 20169
|
| To investigate whether the lysophosphatidic acid receptor 1 and Rho / ROCK signaling are involved in cancer-induced bone pain |
2 x 105
|
PAN et al., 201641
|
| Create a viable prolonged treatment for bone cancer pain |
5 x 105
|
XU et al., 201542
|
| To determine the efficacy of a calpain inhibitor on bone resorption and behavioral responses to pain in vivo in intratibial tumor injected cancer-induced bone pain rats |
1 x 105
|
ZHU et al., 201543
|
| Examine the potential of the spinal sigma-1 receptor in the development of cancer-induced bone pain |
2 x 105
|
WU et al., 201644
|
| Examine the potential role of the spinal PKA/CREB signaling pathway in the development of bone cancer pain |
1 x 105
|
HANG et al., 201345
|
| To investigate whether the chemokine receptor 5 and C-kinase receptor pathway is involved in the maintenance of cancer-induced bone pain |
1 x 105
|
HANG et al., 2013b46
|
| To investigate the effects of intrathecal injection with lipoxin and related analogues on cancer-induced bone pain in rats |
1 x 108
|
HU et al., 201247
|
| To investigate the role of c-jun N-terminal kinase pathway in the spinal cord in cancer-induced bone pain |
3,5 x 105
|
WANG et al., 201248
|
| Femur |
To investigate the hypothesis that urinary levels of N telopeptide (NTx) can be used to predict the anti‑nociceptive responses of zoledronic acid and paclitaxel on bone metastases in a rat model |
1 x 105
|
GUI et al., 201549
|
| Compare the effects of ibandronate and paclitaxel on bone structure and its mechanical properties and biochemical turnover in resorption markers using an immunocompetent Walker 256-Sprague-Dawley model, which was subjected to tumor-induced osteolysis. |
2,5 x 106
|
CHUNG et al., 20155
|
| Establish a model of femoral bone cancer |
1 x 105
|
GUI et al., 201350
|
| Paw |
To investigate the effects of crotoxin on Walker 256 tumor growth, the pain symptoms associated (hyperalgesia and allodynia), and participation of endogenous lipoxin A4 |
1 x 106
|
BRIGATTE et al., 20166
|